Sign up to save your podcasts
Or
Share Amicus Therapeutics CEO John Crowley
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amicus Therapeutics CEO John Crowley
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
8383 ratings
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Talks at GS
View all
Exchanges
965 Listeners
Masters in Business
2,181 Listeners
The Meb Faber Show - Better Investing
938 Listeners
Capital Allocators – Inside the Institutional Investment Industry
799 Listeners
UBS On-Air: Market Moves
184 Listeners
Making Sense
58 Listeners
Value Investing with Legends
212 Listeners
Thoughts on the Market
1,294 Listeners
At Any Rate
76 Listeners
The Memo by Howard Marks
436 Listeners
The Insight by Oaktree Capital
20 Listeners
The Markets
80 Listeners
The View From Apollo
25 Listeners
Joys of Compounding
97 Listeners
Bloomberg Talks
17 Listeners